期刊文献+

长春瑞滨联合顺铂治疗紫杉类化疗失败的复发转移性乳腺癌的临床观察 被引量:1

Clinical observation of vinorelbine plus cisplatin in treatment of recurrent metastatic breast cancer failed taxane chemotherapy
下载PDF
导出
摘要 目的:观察长春瑞滨(NVB)联合顺铂(DDP)治疗复发转移性乳腺癌的疗效。方法:对28例紫杉类化疗后复发转移性乳腺癌患者采用NVB+DDP方案治疗,NVB 25 mg/m2,d1、d8;DDP 25 mg/m2,d1~d3;21天为1个周期,2个周期后评价疗效。结果:28例患者中,完全缓解2例,部分缓解11例,稳定10例,进展5例,总有效率为46.4%。1个部位转移者治疗有效率为50.0%,2个或2个以上部位转移者治疗有效率为43.8%。结论:NVB联合DDP治疗紫杉类化疗失败的复发转移性乳腺癌具有一定疗效,且不良反应可以耐受。 Objective:To investigate the effect of vinorelbine(NVB) plus cisplatin(DDP) regimen on recurrent metastatic breast cancer.Methods:Twenty-eight patients with taxane chemotherapy in patients with metastatic breast cancer were treated with NVB plus DDP program.NVB was 25 mg/m2,iv d1,d8;DDP was 25 mg/m2,iv d1-d3.The period was 21 days.The effect was evaluated after two periods.Results:In 28 patients,complete remission 2 cases,partial remission 11 cases,stable 10 cases,progress 5 cases,the total effective rate was 46.4%.One site metastasis rate was 50.0%,two or more than two parts metastasis rate was 43.8%.Conclusions:NVB plus DDP for treatment of taxane chemotherapy in recurrent metastatic breast cancer with failure plays a certain efficacy,and the toxicity can be tolerated.
出处 《蚌埠医学院学报》 CAS 2010年第12期1223-1224,1227,共3页 Journal of Bengbu Medical College
基金 安徽省卫生厅自然科学研究资助项目(09C172)
关键词 乳腺肿瘤 复发 肿瘤转移 长春瑞滨 顺铂 breast cancer relapse metastasis vinorelbine cisplatin
  • 相关文献

参考文献5

  • 1Shamseddine AI,Taher A,Dabaja B,et al.Combination cisplatin-vinorelbine for relapsed and chemotherapy pretreated metastatic breast cancer[J].Am J Clin Oncol,1999,22(3):298-302.
  • 2Kosmas C,Agclaki S,Giannakakis T,et al.Phasc Ⅰ study of vinorolbinc and carboplatin combination in patients with taxane and anthracycline pretreated advanced breast cancer[J].Oncology,2002,62(2):103-109.
  • 3Bonadonna G.Vinorelbine:an active noncrossresistant drug in advanced breast cancer results from a phase Ⅱ study[J].Breast Cancer Res Treatment,1996,39(3):285-291.
  • 4阮新建,王剑飞,张侠,宋飞翔,郭智.长春瑞滨联合顺铂治疗复发转移乳腺癌43例[J].中国药业,2007,16(15):47-48. 被引量:3
  • 5Vassilomanolakis M,Koumakis G,Demiri M,et al.Vinorelbine and cisplatin for metastatic breast cancer:a salvage regimen in patients progressing after docetaxel and anthracycline treatment[J].Cancer Invest,2003,21(4):497-504.

二级参考文献4

  • 1Bruno S, Puerto VL, Mickie WE, et al. phase Ⅱ trial of weekly intravenous. Vinorelbine as a single agent in first-line advanced breast cancer chemotherapy[J]. Am J Clin Oncol, 1995, 18(5): 390-395.
  • 2Fum oleau P, Delado FM, Pastorino G, et al. phase Ⅱ trial of weekly intravenous Vinorelbine in first-line advanced breast cancer chemotherapy[J]. Am J Clin Oncol, 1993, 11 (7): 1 245 - 1 248.
  • 3Vassilomanolakis M, Koumakis G, Barbounis V, et al. Vinorelbine and cisplatin in metastatic breast cancer patients previouslg treated with anthracgclines[J]. Ann Oncol, 2000, 11 (9): 1 155 - 1 160.
  • 4Bonadonna G. Vinorelbine: an active, non cross - resistant drug in advanced brest cancer. Results from a phase Ⅱ study [ J]. Breast Cancer Research and Treatment, 1996, 39(3): 285 - 291.

同被引文献5

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部